|
?:authorAffiliation
|
-
[\'Infectious Diseases Area, University of Navarra Clinic, Pamplona, Spain jgabaldonfi@unav.es.\', \'Research and Development Department, Hyfe, Wilmington, Delaware, USA.\', \'Immunopathology Axis, Research Center of the University of Montreal Hospital Center, Montréal, Québec, Canada.\', \'Fowler College of Business, San Diego State University, San Diego, California, USA.\', \'Infectious Diseases Area, University of Navarra Clinic, Pamplona, Spain.\', \'School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.\', \'Global Health Institute, Stony Brook University, Stony Brook, New York, USA.\', \'Department of Occupational Medicine - COVID-19 area, University of Navarra Clinic, Pamplona, Spain.\', \'Primary Healthcare, Navarre Health Service-Osasunbidea, Zizur Mayor, Spain.\', \'Department of Microbiology, Infectious Diseases and Immunology, Research Center of the University of Montreal Hospital Center, Montreal, Québec, Canada.\', \'ISGlobal, Hospital Clinic, University of Barcelona, Barcelona, Spain.\', \'Ifakara Institute of Health, Ifakara Institute of Health, Ifakara, Tanzania.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}